Display options
Share it on

Chronic Dis Transl Med. 2018 Dec 13;4(4):268-270. doi: 10.1016/j.cdtm.2018.11.003. eCollection 2018 Dec.

Isoniazid-induced liver disorder in the treatment of tuberculosis.

Chronic diseases and translational medicine

Srinivasan Sivannan, Atukuri Vishnuvardhan, Karthikeyan Elumalai, Sivaneswari Srinivasan, Kalpana Eluri, Manogaran Elumalai, Ramasamy Muthu

Affiliations

  1. Department of Pharmacy Practice, TVM College of Pharmacy, Bellary, 583103, India.
  2. Department of Medicinal Chemistry, The Oxford College of Pharmacy, Hongasandra, Bangalore, 560068, India.
  3. Department of Pharmaceutics, K.K. College of Pharmacy, Gerugambakkam, Chennai, 600128, India.
  4. Faculty of Pharmaceutical Sciences, UCSI University, Cheras, Kuala Lumpur, 56000, Malaysia.
  5. Department of Pharmacology, The Oxford College of Pharmacy, Hongasandra, Bangalore, 560068, India.

PMID: 30603745 PMCID: PMC6308916 DOI: 10.1016/j.cdtm.2018.11.003

[No abstract available.]

References

  1. Hum Exp Toxicol. 2000 Sep;19(9):517-22 - PubMed
  2. Chest. 2005 Jul;128(1):116-23 - PubMed
  3. In Vivo. 2011 Sep-Oct;25(5):803-12 - PubMed
  4. J Clin Exp Hepatol. 2013 Mar;3(1):37-49 - PubMed
  5. Redox Biol. 2015 Dec;6:80-92 - PubMed
  6. Acta Pharm Sin B. 2016 Sep;6(5):384-392 - PubMed
  7. BMC Infect Dis. 2017 Mar 24;17(1):231 - PubMed

Publication Types